India approves the first domestic coronavirus vaccine for human clinical trials

December 12th – On the 12th, local time, the Indian government approved the first domestic mRNA coronavirus vaccine for human clinical trials.

According to a report by New Delhi TV on the 12th, the vaccine, called “HGCO19”, has performed steadily in animal trials and if successfully approved, it will effectively promote India’s vaccination work.

According to the report, the vaccine can be stable in the normal refrigerator refrigeration environment, facilitate transportation to remote areas, and more suitable for India’s needs than other vaccines.